|
Volumn 281, Issue 5376, 1998, Pages 520-521
|
Toward safe and effective medical abortion
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABORTIVE AGENT;
MIFEPRISTONE;
ABORTION;
DRUG DISTRIBUTION;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE DELIVERY;
HEALTH SERVICE;
HUMAN;
INDUCED ABORTION;
MEDICOLEGAL ASPECT;
PRIORITY JOURNAL;
SHORT SURVEY;
BIOMEDICAL RESEARCH;
GENETICS AND REPRODUCTION;
INTERNATIONAL ASPECTS;
METHOTREXATE;
MISOPROSTOL;
RISKS AND BENEFITS;
RU-486;
THERAPEUTIC RESEARCH;
ABORTIFACIENT AGENTS;
ABORTION, INDUCED;
BIOMEDICAL RESEARCH;
DELIVERY OF HEALTH CARE;
DEVELOPING COUNTRIES;
FEMALE;
HUMANS;
INTERNATIONALITY;
LEGISLATION, DRUG;
METHOTREXATE;
MIFEPRISTONE;
MISOPROSTOL;
PREGNANCY;
RISK ASSESSMENT;
THERAPEUTIC HUMAN EXPERIMENTATION;
WOMEN'S HEALTH;
|
EID: 0032563301
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.281.5376.520 Document Type: Short Survey |
Times cited : (8)
|
References (7)
|